Jump to content

Valneva says early studies show COVID-19 vaccine effective against Omicron


Kb27
 Share

Recommended Posts

Valneva says early studies show COVID-19 vaccine effective against Omicron

Jan 19 (Reuters) - French biotech firm Valneva (VLS.PA) said on Wednesday that preliminary studies showed that three doses of its inactivated COVID-19 vaccine candidate neutralised the Omicron variant of the disease.

All of the serum samples tested presented neutralizing antibodies against the ancestral virus and Delta variant, it said, while 87% of samples did so against the Omicron variant.

"We are extremely pleased with these results," said Chief Medical Officer Juan Carlos Jaramillo in a statement, noting that these added to an earlier Phase III trial that showed improved immune response with two doses of the VLA2001 candidate.

Valneva expects to receive potential approvals for its vaccine within the first three months of 2022, and is providing data to the European Medicines Agency (EMA) as well as regulators in the UK and Bahrain.

↡ Advertisement
  • Praise 1
Link to post
Share on other sites

Wait til real world data then say. Now is just own self study say ownself good. Remember early study said pfizer was 88% effective against delta infection after 2 doses. Now we know it' alot lesser than that.

  • Haha! 1
Link to post
Share on other sites

4 hours ago, Jamesc said:

I already had 3 shots of Moderna.

Now need 3 more shots of Vanilla?

:D

Maybe from now on, each and every year a person needs 3 shots ://

  • Haha! 1
Link to post
Share on other sites

22 hours ago, Jamesc said:

I already had 3 shots of Moderna.

Now need 3 more shots of Vanilla?

:D

Take 1 flavour of each for your new ice cream

Vanilla, Sinovax, Novavax 😁

↡ Advertisement
  • Haha! 1
Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
 Share

×
×
  • Create New...